The new Biomedical Research Building will be located immediately east of the Lurie Medical Research Center on the site of the former Prentice Women’s Hospital. Northwestern plans to construct approximately 600,000 square feet of research space starting in 2015 with eventual buildout of approximately 1.2 million square feet.
Navdeep Chandel, PhD, was able to induce cancer cell death by diminishing antioxidant protein activity, leading to an intolerable level of intracellular hydrogen peroxide.
Students, fellows, faculty and guests took part in a mini-symposium that featured two panels discussions, a scientific poster session and networking reception as part of the medical school’s World AIDS Day commemoration.
Although the mechanisms by which interferons, or signaling proteins, generate anti-cancer responses remain to be defined, Leonidas Platanias, MD, PhD, has revealed the essential role that certain enzymes play.
Kathryn Radigan, MD, has received an Early Career Investigator Award from the American Thoracic Society Foundation to study the link between leptin, a hormone that regulates appetite and obesity, and an increased susceptibility to influenza A-induced lung injury.
New study is the first to show that the tongue-controlled system works faster and equally as accurately as the more common sip-and-puff wheelchairs.
Second-year medical student Tiffany Sun sought answers to the progression of cutaneous T-cell lymphoma, a cancer of the immune system, and response to treatments. This research project is part of the Area of Scholarly Concentration, a part of the new curriculum.
A Northwestern University faculty member since 1955, Laszlo Lorand, PhD, is credited with promoting cross-campus collaboration between Evanston and the medical school, while making groundbreaking discoveries in the field of blood coagulation.
Within the United States, the majority of retinoblastoma patients are diagnosed before their second birthday, and many lose their sight due to this disease. In developing nations, advanced retinoblastoma is an even greater clinical challenge and the mortality rate is as high as 70 percent.
New research published by Kristin Swanson, PhD, in PLOS ONE highlights the use of a biomathematical model and optimization algorithm to decrease the amount of radiation received by normal tissue and to increase its impact on brain tumors.